← FDA DRUG APPROVALS

FDA ANDA · ANDA065513

CLINDAMYCIN PHOSPHATE

clindamycin phosphate topical

Sponsor: EPIC PHARMA LLC

APPLICATION
ANDA065513
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-17
LATEST ACTION
2015-05-22
ROUTE
TOPICAL
DOSAGE FORM
SWAB
MARKETING STATUS
Prescription

Products

CLINDAMYCIN PHOSPHATEPrescription
CLINDAMYCIN PHOSPHATE EQ 1% BASE · SWAB · TOPICAL

Approval history

2015-05-22Labeling · Supplement 4 · standardAP
2010-06-17OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →